Table 1 Sample size for available DNA and RNA sequencing data in primary tumors and paired control samples
Cohort | Primary tumor | Matched controls | ||
|---|---|---|---|---|
| Â | Â | Â | Blood | Solid tissue |
| Â | RNA | DNA | DNA | DNA |
AML, acute myeloid leukemia | 123 | nt | nt | nt |
COAD, colon adenocarcinoma | 194 | 77 | 56 | 16 |
KIRK, kidney renal clear carcinoma | 132 | nt | nt | nt |
KIRP, kidney renal papillary cell carcinoma | 15 | nt | nt | nt |
LUAD, lung adenocarcinoma | 58 | nt | nt | nt |
LUSK, lung squamous cell carcinoma | 151 | nt | nt | nt |
READ, rectum adenocarcinoma | 71 | 40 | 35 | 4 |
STAD, stomach adenocarcinoma | 57 | 3 | 0 | 2 |
UCEC, uterine corpus endometrioid carcinoma | 157 | nt | nt | nt |